
First patient dosed in REVEAL pivotal trial evaluating TSHA-102 (N=15, aged 6 to
On 6ix: 6ix.com/news/taysha-gene-therapies-announces-progress-across-tsha-102-pivotal-gene-therapy-program

First patient dosed in REVEAL pivotal trial evaluating TSHA-102 (N=15, aged 6 to
Taysha Gene Therapies, Inc. on 6ix
Follow Taysha Gene Therapies into a list and get an email when it puts out news.
Follow Taysha Gene Therapies